References
- Sobel JD. Vaginitis. N Engl J Med 1997; 337: 1896–1903
- Sobel JD, Broker D, Stein GE, et al. Single oral dose of fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole vaginitis Study Group. Am J Obstet Gynecol 1995; 172: 1263–1268
- Galgiani JN, Lewis ML. In vitro studies of activities of the antifungal triazoles SCH 56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob Agents Chemother 1997; 41: 180–183
- Cacciapuoti A, Loebenberg D, Corcoran E, et al. In vitro and in vivo activities of SCH 56592 (Posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother 2000; 44: 2017–2022
- Perfect JR, Cox GM, Dodge RK, Schell WA. In vitro and in vivo efficacies of the azole SCH 56592 against Cryptococcus neoformans. Antimicrob Agents Chemother 1996; 40: 1910–1913
- Kirkpatrick WR, McAtee RA, Fothergill A, et al. Efficiency of SCH 56592 in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother 2000; 44: 780–782
- Connolly P, Wheat LJ, Schnizlein-Bick C, et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000; 44: 2604–2608
- Lutz JE, Clemons KV, Aristizabal BH, Stevens DA. Activity of the triazole SCH 56592 against disseminated murine coccidioidomicosis. Antimicrob Agents Chemother 1997; 41: 1558–1561
- González GM, Tijerina R, Najvar LK, et al. In vitro and in vivo activities of posaconazole against Coccidioides immitis. Antimicrob Agents Chemother 2002; 46: 1352–1356
- Sugar AM, Liu X-P. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother 1996; 40: 1314–1316
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. 2002. Approved standard M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
- Calderon L, Williams R, Martinez M, Clemons KV, Stevens DA. Genetic susceptibility to vaginal candidiasis. Med Mycol 2003; 41: 143–147
- Ryley JF, McGregor S. Quantification of vaginal Candida albicans infections in rodents. J Med Vet Mycol 1986; 24: 455–460
- Pfaller MA, Bale M, Buschelman B, et al. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J Clin Microbiol 1995; 33: 1104–1107